| Exscientia Ltd.. (7/21/21). "Press Release: Exscientia and GT Apeiron Therapeutics Enter Oncology Joint Venture". Oxford & Shanghai. |
2021-07-21 |
| Exscientia Ltd.. (7/8/21). "Press Release: Exscientia Accelerates COVID-19 Drug Discovery Using AI". Oxford. |
2021-07-08 |
| Exscientia Ltd.. (8/18/20). "Press Release: Europe’s Largest Initiative Launches to Accelerate Therapy Development for COVID-19 and Future Coronavirus Threats". Brussels. |
2020-08-18 |
| Exscientia Ltd.. (8/18/21). "Press Release: Bristol Myers Squibb Exercises Option to Develop Exscientia’s AI-designed, Immune-modulating Drug Candidate". Oxford. |
2021-08-18 |
| Exscientia Ltd.. (8/4/21). "Press Release: Exscientia Builds Automated Laboratories in Oxford to Expand Pipeline". |
2021-08-04 |
| Exscientia Ltd.. (8/5/19). "Press Release: Sanofi Exercises Option on Exscientia-designed Bispecific Small Molecule for Treatment of Immunological Conditions". |
2019-08-05 |
| Exscientia Ltd.. (9/29/20). "Press Release: Exscientia Appoints Industry R&D Veteran, David Nicholson, as Chairman as Company Extends Pipeline". |
2020-09-29 |
| Exscientia Ltd.. (9/8/21). "Press Release: Exscientia Enters $70M Collaboration to Develop Anti-viral Therapeutics against Coronavirus and other Viruses with Pandemic Potential". |
2021-09-08 |
| Exscientia Ltd.. (9/9/20). "Press Release: Huadong Medicine and Exscientia Enter Co-development Partnership to Accelerate Oncology Drug Discovery through Artificial Intelligence". |
2020-09-09 |
| Exscientia plc. (1/7/22). "Press Release: Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline of Precision-Engineered Medicines". Paris, Oxford & Boston, MA. |
2022-01-07 |
| Exscientia plc. (10/17/23). "Press Release: Parker Moss to Join Exscientia as EVP, Corporate Development". Oxford. |
2023-10-17 |
| Exscientia plc. (10/3/23). "Press Release: Exscientia Details Pipeline Prioritisation Strategy". Oxford. |
2023-10-03 |
| Exscientia plc. (10/5/21). "Press Release: Exscientia Announces Closing of $510.4 Million Aggregate Financing". Oxford. |
2021-10-05 |
| Exscientia plc. (11/1/22). "Press Release: Exscientia to Present at Upcoming Investor Conferences in November". Oxford. |
2022-11-01 |
| Exscientia plc. (11/21/23). "Press Release: Exscientia to Present at the 6th Annual Evercore ISI HealthCONx Conference". Oxford. |
2023-11-21 |
| Exscientia plc. (11/3/22). "Press Release: Exscientia Expands Biologics Design Capability with Automated Laboratory". Oxford. |
2022-11-03 |
| Exscientia plc. (12/5/23). "Press Release: Exscientia Receives Open Philanthropy Grant to Explore New Therapeutic Approach for Pandemic Influenza". Oxford. |
2023-12-05 |
| Exscientia plc. (3/14/23). "Press Release: Exscientia Announces Expansion of its Precision Oncology Pipeline". Oxford. |
2023-03-14 |
| Exscientia plc. (3/7/23). "Press Release: Exscientia Announces Collaboration with Charité to Advance Development of Precision Medicine Platform". Oxford & Berlin. |
2023-03-07 |
| Exscientia plc. (6/6/23). "Press Release: Exscientia to Present at the Goldman Sachs 44th Annual Global Healthcare Conference". Oxford. |
2022-06-06 |
| Exscientia plc. (8/31/23). "Press Release: Exscientia to Present at Upcoming Investor Conferences in September". Oxford. |
2023-08-31 |
| Exscientia plc. (9/20/23). "Press Release: Exscientia Announces AI Drug Discovery Collaboration with Merck KGaA, Darmstadt, Germany". Oxford. |
2023-09-20 |
| Exscientia plc. (9/30/21). "Press Release: Exscientia Announces Pricing of $304.7 Million Upsized Initial Public Offering and $160.0 Million Concurrent Private Placements". Oxford. |
2021-09-30 |
| Eyebiotech Ldt.. (2/22/22). "Press Release: EyeBio Raises $65M in Series A Funding to Develop New Generation of Eye Disease Therapies". London & New York, NY. |
2022-02-22 |
| F-Star Biotechnology Ltd.. (1/9/18). "Press Release: F-Star Provides an Update on Its Collaboration with Denali Therapeutics". Cambridge. |
2018-01-09 |
| F-Star Biotechnology Ltd.. (10/15/18). "Press Release: F-star Appoints Dr Eliot Forster as Chief Executive Officer". Cambridge. |
2018-10-15 |
| F-Star Biotechnology Ltd.. (3/25/19). "Press Release: F-star Presents New Data on its Tetravalent Bispecific Antibodies at the AACR 2019 Annual Meeting". Cambridge. |
2019-03-25 |
| F-Star Biotechnology Ltd.. (5/14/19). "Press Release: F-star Expedites Its Transition to a Wholly-owned Portfolio Strategy". Cambridge. |
2019-05-14 |
| F-Star Biotechnology Ltd.. (5/21/18). "Press Release: F-Star Announces First Patient Dosed in Phase I Clinical Trial of FS118, a First-in-class Immuno-oncology Bispecific Antibody". Cambridge. |
2018-05-21 |
| F-Star Biotechnology Ltd.. (5/30/18). "Press Release: F-Star Announces Early Exercise by Denali Therapeutics of Its Option to Acquire F-star Gamma". Cambridge. |
2018-05-30 |
| F-Star Biotechnology Ltd.. (6/4/17). "Press Release: F-star Expands Its Relationship with Merck through a New Strategic Collaboration to Develop Bispecific Antibodies in Immuno-Oncology". Cambridge. |
2017-06-04 |
| F-Star Biotechnology Ltd.. (9/10/18). "Press Release: F-star Appoints Nessan Bermingham as Chairman of its Board of Directors". Cambridge. |
2018-09-10 |
| F-Star Therapeutics Ltd.. (10/20/21). "Press Release: F-star Therapeutics Announces License Agreement with Janssen to Develop and Commercialize Multiple Next Generation Bispecific Antibody Therapeutics". Cambridge & Cambridge, MA. |
2021-10-20 |
| F-Star Therapeutics, Inc.. (6/23/22). "Press Release: invoX Pharma to Acquire F-star Therapeutics, Inc. a Pioneering Next Generation Bispecific Discovery Platform and Clinical Programs". London. |
2022-06-23 |
| F2G Ltd.. (1/7/19). "Press Release: F2G Expands Investor Syndicate and Progresses Phase IIb Study for Novel Antifungal". Manchester. |
2019-01-07 |
| F2G Ltd.. (1/9/17). "Press Release: F2G Ltd Receives European Orphan Drug Designation for its Lead Candidate F901318". Manchester. |
2017-01-09 |
| F2G Ltd.. (11/22/18). "Press Release: EU Supports F2G Biotech in Austria with EUR 24 Million for Antifungal Research and Innovation". Luxembourg. |
2018-11-22 |
| F2G Ltd.. (4/12/21). "Press Release: Francesco Maria Lavino Appointed Chief Executive Officer of F2G Ltd". Manchester & Vienna. |
2021-04-12 |
| F2G Ltd.. (5/16/22). "Press Release: Shionogi Co., Ltd. and F2G Enter Strategic Collaboration to Develop and Commercialize the New Antifungal Agent Olorofim in Europe and Asia". Osaka & Manchester. |
2022-05-16 |
| F2G Ltd.. (8/4/22). "Press Release: F2G Announces $70 Million Financing to Advance Development and Commercialization of New Antifungal Agent Olorofim". Manchester. |
2022-08-04 |
| FIRE1 (Foundry Innovation & Research 1, Ltd.). (1/30/18). "Press Release: FIRE1 Raises EUR 40 Million in Series C Financing". Dublin. |
2018-01-30 |
| Five Alarm Bio Ltd.. (2/27/23). "Press Release: Five Alarm Bio, Focused on Minimising the Effects of Aging in Humans, Raises Seed Investment". Cambridge. |
2023-02-27 |
| Fluidigm Corporation. (5/4/17). "Press Release: European Mass Cytometry Consortium Brings CyTOF Technology to Leading Universities to Advance Clinical Research". South San Francisco, CA. |
2017-05-04 |
| Fortis Technologies Ltd.. (6/30/17). "Press Release: New SpeedCore C18-PFP for High Resolution LC Separations". Cheshire. |
2017-06-30 |
| Fountain Healthcare Partners. (11/2/20). "Press Release: Fountain Healthcare Partners Announces Final Close of €125 Million for Fund III". |
2020-11-02 |
| Fountain Healthcare Partners. (5/23/19). "Press Release: Fountain Healthcare Partners Raises €118M for Third Fund. Fund Raise Exceeds Target of €100m". Dublin & New York, NY. |
2019-05-23 |
| Francis Crick Institute Ltd., The. (7/11/22). "Press Release: £1billion Invested in the Future of UK Discovery Science". |
2022-07-11 |
| Freeline Therapeutics Holdings plc. (11/22/23). "Press Release: Syncona to Acquire Freeline Therapeutics". London. |
2023-11-22 |
| Freeline Therapeutics Holdings plc. (2/10/23). "Press Release: Freeline Announces Closing of Sale of Its CMC-focused German Subsidiary". London. |
2023-02-10 |
| Freeline Therapeutics Ltd.. (19/12/19). "Press Release: Syncona Makes a Further $80 Million Commitment to Freeline". London. |
2019-12-19 |
| Freeline Therapeutics Ltd.. (2/12/20). "Press Release: Freeline Presents Data on Its AAV-based Gene Therapies for Fabry Disease and Gaucher Disease at the 16th annual WORLDSymposium". London. |
2020-02-12 |
| Freeline Therapeutics Ltd.. (2/4/20). "Press Release: Freeline Appoints Theresa Heggie as Chief Executive". London. |
2020-02-04 |
| Freeline Therapeutics Ltd.. (5/4/20). "Press Release: Freeline Receives Orphan Drug Designation from the FDA for FLT190 for the Treatment of Fabry Disease". London. |
2020-05-04 |
| Freeline Therapeutics Ltd.. (6/13/19). "Press Release: Freeline Announces Senior Leadership Transition and Completion of Series B Financing Milestones". |
2019-06-13 |
| Freeline Therapeutics Ltd.. (6/19/18). "Press Release: Freeline Secures Over £88 Million of Funding". London. |
2018-06-19 |
| Freeline Therapeutics Ltd.. (6/30/20). "Press Release: Freeline Closes $120 Million Series C Financing Round". London. |
2020-06-30 |
| Freeline Therapeutics Ltd.. (7/10/17). "Press Release: Freeline Therapeutics Appoints Anne Prener as Chief Executive Officer". |
2017-07-10 |
| Fujifilm Diosynth Biotechnologies UK Ltd.. (12/2/21). "Press Release: Fujifilm Diosynth Biotechnologies Confirms £400 Million Investment Plans to Create the Largest Multi-modal Biopharmaceutical Manufacturing Site in the United Kingdom". Billingham. |
2021-12-02 |
| Fusion Antibodies Ltd.. (11/6/20). "Press Release: Fusion Antibodies Announce New Senior Hire to Support Innovation". |
2020-11-06 |
| Future Planet Capital Ltd.. (4/8/21). "Press Release: Future Planet Acquires One of the UK’s Oldest VC Firms". |
2021-04-08 |
| GammaDelta Therapeutics Ltd.. (10/16/19). "Press Release: Adaptate Biotherapeutics Formed to Develop Antibody-based Therapies that Modulate Gamma Delta T-cells". London. |
2019-10-16 |
| GammaDelta Therapeutics Ltd.. (10/27/21). "Press Release: Takeda to Acquire GammaDelta Therapeutics to Accelerate Development of Allogeneic gdT Cell Therapies Addressing Solid Tumors". Osaka & London. |
2021-10-27 |
| GammaDelta Therapeutics Ltd.. (5/3/17). "Press Release: GammaDelta Therapeutics Expands Management Team Led by Paolo Paoletti as CEO". London. |
2017-05-03 |
| Genedata AG. (2/21/17). "Press Release: Genedata Expands into United Kingdom". Basel. |
2017-02-21 |
| Genedrive plc. (5/14/18). "Press Release: Proposed Disposal of the Company's Contract Research and Pharmacogenomics Divisions for up to £1.9 Million in Cash". |
2018-05-14 |
| Genedrive plc. (9/10/21). "Press Release: Placing to Raise up to £6.0 Million and Open Offer to Raise Up to £4.5 Million and Notice of General Meeting [NOT FOR US, AU, CA, JP, et al.]". Manchester. |
2021-09-10 |
| Genedrive plc. (9/10/21). "Press Release: Successful Completion of £6.0 million Placing [NOT FOR US, AU, CA, JP, et al.]". Manchester. |
2021-09-10 |
| Genomics England Ltd.. (1/25/19). "Press Release: Jonathan Symonds Appointed New Chair of Genomics England". |
2019-01-25 |
| Genomics England Ltd.. (1/8/18). "Press Release: Genomics England Adopts Edico Genome’s DRAGEN Bio-IT Platform". |
2018-01-08 |
| Genomics England Ltd.. (10/13/17). "Press Release: Genomics England Partners with Inivata and Thermo Fisher Scientific". |
2017-10-13 |
| Genomics England Ltd.. (11/15/18). "Press Release: Helomics Partners with Genomics England’s Discovery Forum to Drive Precision Medicine for Ovarian Cancer". |
2018-11-15 |
| Genomics England Ltd.. (12/5/18). "Press Release: The UK Has Sequenced 100,000 Whole Genomes in the NHS.
Pioneering 100,000 Genomes Project Reaches Its Goal and Thanks All Involved". |
2018-12-05 |
| Genomics Medicine Ireland Ltd.. (11/27/18). "Press Release: $400 Million Investment Programme Positions Ireland for Global Leadership in Genomic Research and Advanced Life Sciences". |
2018-11-27 |
| Genomics Medicine Ireland Ltd.. (11/6/18). "Press Release: GMI Appoints Dr. Anne Jones as CEO". |
2018-11-06 |
| Genomics Medicine Ireland Ltd.. (11/7/18). "Press Release: GMI Genomics Centre Awarded CAP-Accreditation". |
2018-11-07 |
| Genomics Medicine Ireland Ltd.. (12/11/17). "Press Release: Genomics Medicine Ireland Research Study Aims to Unlock Answers to MS". Cork. |
2017-12-11 |
| Genomics Medicine Ireland Ltd.. (3/30/17). "Press Release: Genomics Medicine Ireland Announces Two Appointments to Its Board. Dr. Kari Stefánsson and Dr. Paul Saunders Appointed to the Board". Dublin. |
2017-03-30 |
| Genomics Medicine Ireland Ltd.. (8/12/19). "Press Release: Genomics Medicine Ireland Announces Strategic Advisory Board". |
2019-08-12 |
| Genomics Medicine Ireland Ltd.. (8/30/18). "Press Release: Genomics Medicine Ireland and University of Cambridge Announce Multiple Sclerosis Research Collaboration". Dublin. |
2018-08-30 |
| Genomics plc. (1/16/18). "Press Release: Jeff Barrett Joins Genomics plc as CSO". Oxford. |
2018-01-16 |
| Genomics plc. (10/16/17). "Press Release: Genomics plc Teams Up with Biogen to Discover New Drug Targets for Multiple Sclerosis". Oxford. |
2017-10-16 |
| Genomics plc. (10/5/20). "Press Release: Daniel Vogel Joins Genomics plc as Chief Financial Officer". Oxford. |
2020-10-05 |
| Genomics plc. (12/10/18). "Press Release: Genomics plc Today Announces Second Close of Its Series B Financing, Raising a further £8 Million, Bringing the Total Round to £33 million
". Oxford. |
2018-12-10 |
| Genomics plc. (3/9/20). "Press Release: Mitchell Harris Joins Genomics plc as Chief Strategy Officer". Oxford. |
2020-03-09 |
| Genomics plc. (8/28/18). "Press Release: Opening of Cambridge Office". Cambridge. |
2018-03-28 |
| Genomics plc. (8/30/18). "Press Release: Genomics plc Raises £25 million in Series B Round to Advance Its Use of Human Genetics and Data Science in Drug Discovery". Oxford. |
2018-08-30 |
| Genomics plc. (8/30/18). "Press Release: Vertex and Genomics plc Establish Collaboration to Use Human Genetics and Data Science to Advance Discovery of Precision Medicines". Boston, MA & Oxford. |
2018-08-30 |
| genOway S.A.. (1/25/22). "Press Release: genOway Grants the Leading UK Academic Research Funder a Non-exclusive License for CRISPR/Cas9 Technology". Lyon. |
2022-01-25 |
| GHO Capital Partners LLP. (11/20/19). "Press Release: GHO Capital Raises €975m in Largest Ever European Healthcare Fund". London. |
2019-11-20 |
| GHO Capital Partners LLP. (6/3/20). "Press Release: GHO Capital Acquires X-Chem, a Leading Drug Discovery Service Provider". London. |
2020-06-03 |
| GlaxoSmithKline plc. (1/19/17). "Press Release: Abbas Hussain to Leave GSK". London. |
2017-01-19 |
| GlaxoSmithKline plc. (1/19/17). "Press Release: Luke Miels Appointed President, Global Pharmaceuticals, GSK". London. |
2017-01-19 |
| GlaxoSmithKline plc. (1/21/19). "Press Release: GSK Announces Succession Plan to Appoint New Chairman". |
2019-01-21 |
| GlaxoSmithKline plc. (1/22/19). "Press Release: GSK Completes Acquisition of Tesaro, an Oncology Focused Biopharmaceutical Company". London. |
2019-01-22 |
| GlaxoSmithKline plc. (1/26/18). "Press Release: GSK Announces CHMP Positive Opinion for Labelling Update to Relvar Ellipta in Patients with Asthma". London. |
2018-01-26 |
| GlaxoSmithKline plc. (1/26/18). "Press Release: GSK’s Shingrix Receives Positive Opinion from the CHMP in Europe for the Prevention of Shingles in Adults Aged 50 and Over". London. |
2018-01-26 |
| GlaxoSmithKline plc. (1/8/20). "Press Release: Deborah Waterhouse, CEO of ViiV Healthcare, to Join GSK Corporate Executive Team (CET)". London. |
2020-01-08 |
| GlaxoSmithKline plc. (10/25/17). "Press Release: GSK Delivers Q3 Sales of £7.8 billion, +4% AER, +2% CER". London. |
2017-10-25 |
| GlaxoSmithKline plc. (10/27/17). "Press Release: Public-private Consortium Aims to Cut Preclinical Cancer Drug Discovery from Six Years to Just One". San Francisco, CA. |
2017-10-27 |
| GlaxoSmithKline plc. (10/27/17). "Press Release: ViiV Healthcare Announces Positive Phase 3 results from the BRIGHTE Study of Fostemsavir in Heavily Treatment-experienced Patients with HIV". London. |
2017-10-27 |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
